NanoEngineering
NanoEngineering: Innovating biomedicine with nanoscopic tools for virus and vaccine analysis.
Founded
2004NanoEngineering: Innovating biomedicine with nanoscopic tools for virus and vaccine analysis.
NanoEngineering, founded with a mission to revolutionize biomedicine, focuses on developing advanced bio-medical tools for nanoscopic analysis of intact viruses, vaccines, and virus-like particles. The company's core vision is to enhance the precision and efficiency of virus and vaccine analysis through innovative nanotechnology. Their primary products include high-resolution ES-DMA systems designed to detect, quantify, and characterize nanoparticles ranging from 1-250 nm. NanoEngineering serves markets in viral diagnostics, biologics, point-of-care testing, environmental research, and industrial testing.
Notable affiliated individuals and investors include experts in nanotechnology and biomedical engineering, though specific names are not provided. Key achievements of NanoEngineering include the successful development and deployment of their ES-DMA systems in various scientific and industrial applications. The overall impact of NanoEngineering lies in its contribution to more accurate and efficient virus and vaccine analysis, which is crucial for advancing public health and safety.
Companies similar to NanoEngineering include NanoDx, Nanostream, Evizia and NanoHybrids.
NanoEngineering was founded in 2004.
NanoEngineering's headquarters is located in Boca Raton, FL, US.
NanoEngineering's most recent funding round was for $1.3M (USD) in January 2015.
As of Jan 16, 2015, NanoEngineering has disclosed funding of $1.3M (USD). Undisclosed round amounts are excluded.
NanoEngineering has 9 employees as of Feb 5, 2024.
nanohybrids.net
